高龄非男性因素不孕中卵胞浆内单精子注射的作用
这项回顾性单中心研究纳入2012年1月至2015年6月间745例40-43岁非男性因素不孕行IVF的女性,其中490例接受ICSI、255例接受常规IVF。校正混杂因素后两组活产率相似(11.9% vs 9.6%),ICSI未见优于常规IVF。
要点
- 40岁及以上非男性因素不孕女性中,ICSI较常规IVF无活产率优势。
- 常规IVF组MII卵数(6.1 vs 4.7,P<0.0001)和形成受精卵数(4.48 vs 3.66,P=0.001)更高。
- 是否行ICSI应基于精子参数和既往病史,仅因高龄使用ICSI无获益。
核心结论
- 在40岁及以上非男性因素不孕女性中,ICSI较常规IVF无生殖结局优势,活产率相似(11.9% vs 9.6%)。
研究设计与样本
- 回顾性单中心研究,纳入2012年1月至2015年6月间40-43岁因非男性因素不孕接受IVF治疗的745例女性,其中490例行ICSI、255例行常规IVF。
主要发现
- ICSI组既往IVF周期数高于常规IVF组(1.0 vs 0.6,P=0.0001)。
- 取卵数相似(7.2 vs 6.5),但常规IVF组MII卵数更高(6.1 vs 4.7,P<0.0001),形成受精卵数更多(4.48 vs 3.66,P=0.001)。
- 常规IVF组移植囊胚周期比例更高(36% vs 26%,P=0.005),可冷冻胚胎周期比例更高(26.4% vs 19.7%,P=0.048)。
- 受精率(64% vs 67%)和受精失败率(9.0% vs 9.7%)两组相似。
- logistic回归校正混杂因素后,两组活产率相似(11.9% vs 9.6%);首次IVF周期和取卵数≤3个的亚组分析亦未见ICSI优势。
临床怎么用
- 作者认为,是否行ICSI应基于精子参数和既往病史;仅因高龄这一指征使用ICSI较常规IVF无获益。
局限性
- 研究的回顾性性质是主要局限性。
- ICSI组既往IVF周期数更高,可能意味着ICSI被用于预后更差的患者。
- 基于事后效力分析,该研究检测活产率差异的效力仍不足,可能限制研究结论。
- 需要前瞻性研究来证实本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does ICSI improve reproductive outcomes compared with conventional IVF when used for non-male factor infertility in women aged 40 years and over? SUMMARY ANSWER: There is no advantage of ICSI over conventional IVF in women aged 40 years and over when used for non-male factor infertility. WHAT IS KNOWN ALREADY: The use of ICSI has increased dramatically in recent years and is being applied for indications other than male factor infertility. Currently, ICSI is used in 65% of IVF cycles in Europe and in 76% of cycles in the USA. Despite its increase use, there is no clear evidence of a benefit in using ICSI over conventional IVF. Older women undergoing infertility treatments are at an increased risk of having diminished ovarian reserve and lower oocyte quality, which could make ICSI the preferred insemination method in this group. However, studies that have examined the benefits of ICSI in this age group are lacking. STUDY DESIGN, SIZE, DURATION: A retrospective, single center study included women, aged 40-43 years, who underwent IVF treatments for non-male factor infertility between January 2012 until June 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 745 women were included in the study. Of these, 490 women underwent ICSI and 255 women underwent conventional IVF. In order to be included in the study, women had to be at least 40 years of age at the beginning of ovarian stimulation and their male partner had to have normal sperm parameters according to World Health Organisation (WHO) fifth edition. Exclusion criteria included: more than three previous IVF cycles, a history of fertilization failure or low fertilization (<50%), the use of donor or frozen oocytes and the use of donor or frozen sperm samples. The primary outcome was the live birth rate. Secondary outcomes included fertilization rates, fertilization failure and embryo quality. MAIN RESULTS AND THE ROLE OF CHANCE: Baseline characteristics were similar between the two groups, except for the number of previous IVF cycles, which was higher in the ICSI group (1.0 vs. 0.6, P = 0.0001). Despite similar numbers of oocytes retrieved (7.2 vs. 6.5), when examining oocytes maturity (performed 2 h after oocyte retrieval in the ICSI group and after 18 h in the conventional IVF group), the conventional IVF group had a higher number of Metaphase II (MII) oocytes (6.1 vs. 4.7, P < 0.0001). The conventional IVF group also had higher numbers of zygotes formed (4.48 vs. 3.66, P = 0.001), more cycles with embryos transferred at the blastocyst stage (36 vs. 26%, P = 0.005) and more cycles where embryos were available for cryopreservation (26.4 vs. 19.7%, P = 0.048), compared with the ICSI group. The fertilization rates (64 vs. 67%) and fertilization failure (9.0 vs. 9.7%) were similar. After logistic regression analysis controlling for confounders, the live birth rates were similar between the groups (11.9 vs. 9.6%). Subgroup analyses of women undergoing their first IVF cycle and women with ≤3 oocytes retrieved did not show an advantage of ICSI over conventional IVF. LIMITATIONS, REASONS FOR CAUTION: The retrospective nature of this study was a major limitation. The ICSI group had a higher number of previous IVF cycles, which could mean that ICSI was performed in poorer prognosis patients. Moreover, although this study is one of the largest studies to examine the question of whether ICSI is of value for older women with non-male factor infertility, based on a post hoc power analysis, it was still underpowered to detect differences in live birth rates, which can limit the conclusions of the study. Prospective studies are needed to confirm our findings. WIDER IMPLICATIONS OF THE FINDINGS: The decision regarding performing ICSI should be based on sperm parameters and previous history. The use of ICSI for the sole indication of advanced maternal age shows no benefit over conventional IVF. STUDY FUNDING/COMPETING INTERESTS: None. TRIAL REGISTRATION NUMBER: N/A.
引用
- Tannus S, Son WY, Gilman A, et al. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age. Hum Reprod. 2016. PMID: 27852688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。